1. Market Research
  2. > Therapy Market Trends
  3. > Antimigraine Industry

Antimigraine Industry Statistics

You might be interested in: Pharmaceutical, Pain Relief, Hospital, Cardiovascular Disease, Healthcare, Therapy, Analgesic, Opioid, Hormone, Cardiovascular Drug, Chemotherapy, Anti-Infective, Antidepressant.

1-10 of 87 reports for Antimigraine

Pain Relief Industry in the US

  • January 2016
    6 pages
  • Pain Relief  

    Antimigraine  

  • United States  

View report >

Analgesic Market in the US

  • June 2018
    86 pages
  • Analgesic  

    Allergy Drug  

    Gastrointestina...  

  • United States  

View report >

Hospital Social Impact in the US and Denmark

  • December 2017
    16 pages
  • Hospital  

    Analgesic  

  • United States  

    Denmark  

    Europe  

View report >

Opioid Market in the US

  • January 2016
    137 pages
  • Opioid  

    Analgesic  

    Pain Relief  

  • United States  

View report >

Opioid Market in the US and India

  • May 2017
    9 pages
  • Opioid  

    Analgesic  

  • United States  

    India  

View report >

Pharmaceutical Industry in India

  • January 2016
    112 pages
  • Pharmaceutical  

    Anti-Infective  

  • India  

    Asia  

View report >

AstraZeneca PLC - Annual Report, 2016

  • January 2016
    279 pages
  • Pharmaceutical  

    Therapy  

  • United States  

View report >

AstraZeneca PLC - Analyst Report, 2017

  • January 2017
    275 pages
  • Pharmaceutical  

    Therapy  

  • United States  

View report >

Opioid Market in the US

  • January 2018
    152 pages
  • Opioid  

    Analgesic  

    Pain Relief  

  • United States  

View report >

Opioid Market in the US

  • January 2018
    152 pages
  • Opioid  

    Analgesic  

    Pain Relief  

  • United States  

View report >
17 reports for Antimigraine

Purchase Reports From Reputable Market Research Publishers
(From $ 599 - $ 10995)

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2026

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • Industry report
  • August 2017
  • by GlobalData

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2026SummaryMigraine is a complex neurological condition, characterized by frequent headaches that can last between four and 72 hours. ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on